Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: EUROAPI

Market Cap 121M 139M 111M 104M 195M 13.26B 198M 1.32B 512M 6.45B 523M 512M 22.34B P/E Ratio 2026 *
-1.59x
P/E Ratio 2027 * -3.44x
Enterprise Value 78.85M 91.2M 72.66M 68.03M 128M 8.68B 129M 862M 335M 4.22B 342M 335M 14.62B EV / Sales 2026 *
0.1x
EV / Sales 2027 * 0.14x
Free-Float
64.99%
Yield 2026 *
-
Yield 2027 * -
3 months+22.05%
6 months-56.82%
Current year-41.06%
Current year 1.27
Extreme 1.27
2.54
1 year 1.27
Extreme 1.27
3.74
3 years 1.27
Extreme 1.27
12.7
5 years 1.27
Extreme 1.27
23.4
10 years 1.27
Extreme 1.27
23.4
Manager TitleAgeSince
Chief Executive Officer - 09/12/2024
Director of Finance/CFO - 17/10/2024
Compliance Officer - 27/11/2023
Director TitleAgeSince
Director/Board Member 62 06/05/2022
Director/Board Member - 06/05/2022
Chairman 57 09/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 140M
-2.41%+0.14%+38.28%+154.20% 1,010B
+1.07%+3.48%+53.32%+49.85% 580B
+1.32%+0.22%+19.18%+64.65% 402B
+0.77%0.00%+19.99%+16.80% 330B
-1.42%-1.44%+45.70%+8.24% 294B
-0.85%-2.86%+22.05%+13.80% 280B
+0.44%+3.48%+24.48%+34.39% 281B
+1.66%+1.20%-44.67%-47.49% 197B
+0.32%+1.61%+19.48%+63.42% 192B
Average +0.09%+1.17%+21.98%+39.76% 396.34B
Weighted average by Cap. -0.33%+0.90%+29.53%+65.88%

Financials

2026 *2027 *
Net sales 760M 880M 701M 656M 1.23B 83.68B 1.25B 8.31B 3.23B 40.73B 3.3B 3.23B 141B 804M 931M 741M 694M 1.3B 88.52B 1.32B 8.79B 3.42B 43.09B 3.49B 3.42B 149B
Net income -75.7M -87.56M -69.77M -65.31M -122M -8.33B -124M -827M -322M -4.05B -329M -322M -14.03B -40.25M -46.56M -37.1M -34.73M -65.12M -4.43B -66.07M -440M -171M -2.16B -175M -171M -7.46B
Net Debt -41.66M -48.19M -38.4M -35.95M -67.4M -4.58B -68.38M -455M -177M -2.23B -181M -177M -7.72B -5.06M -5.86M -4.67M -4.37M -8.19M -557M -8.31M -55.34M -21.51M -271M -21.98M -21.51M -939M
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
12/06/26 - $ - 8
11/06/26 - $ - 3
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
5
Last Close Price
1.266EUR
Average target price
1.760EUR
Spread / Average Target
+39.02%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!